Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357316 · ClinicalTrials.gov registry record
Heritability and Genetics of Fat Taste
A clinical trial, sponsored by Purdue University.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT02357316: Completed study, sponsored by Purdue University.
NCT02357316 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02357316 has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The investigators seek to determine how genetics and the environment influence the ability to taste and smell fat. The investigators believe that people who consume higher fat diets and people who have higher body fat levels are less able to taste and smell fat. The investigators expect to see that people who are less able to taste and smell fat will share certain genetic differences.
Primary Outcome
Intensity ratings of linoleic acid will be measured using a visual analog scale.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-12 |
What the finished NCT02357316 record still lists
NCT02357316 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02357316 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02357316 about?
NCT02357316 is a clinical study titled "Heritability and Genetics of Fat Taste". The investigators seek to determine how genetics and the environment influence the ability to taste and smell fat. The investigators believe that people who consume higher fat diets and people who have higher body fat levels are less able to taste and smell fat. The investigators expect to see that ...
What is the current status of trial NCT02357316?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2013-11. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02357316?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia